Publication:
Cancer Chemotherapy and Liver

Simple item page
dc.authorscopusid6701685009
dc.authorscopusid57197626318
dc.contributor.authorŞahan, C.
dc.contributor.authorÖztürk, M.
dc.date.accessioned2025-12-11T02:11:56Z
dc.date.issued2003
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Şahan] Cem, Tip Fakultesi Ic Hastaliklari AD, Ondokuz Mayis Üniversitesi, Samsun, Turkey,; [Öztürk] Murat, Zonguldak Bulent Ecevit University, Zonguldak, Zonguldak, Turkeyen_US
dc.description.abstractThe potential hepatotoxicity from cancer chemotherapy may be complex. Liver injury during cancer chemotherapy may not always reflect hepatotoxic anticancer drugs; the clinician must also consider reactions to antibiotics, analgesic, antiemetic other medications. Preexisting medical problems, tumor, immumosuppression, hepatitis viruses and other infections and nutrition deficiencies all may affect a host susceptibility to liver injury. Drugs that commonly produce hepatotoxicity are L-asparaginase, methotrexate, cytrabine, 6-thiopurines and mitramycin. The review discusses the effect of chemotherapeutic agents on the liver.en_US
dc.identifier.endpage60en_US
dc.identifier.issn1300-2996
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-0041819563
dc.identifier.scopusqualityN/A
dc.identifier.startpage47en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/47771
dc.identifier.volume20en_US
dc.identifier.wosqualityN/A
dc.language.isotren_US
dc.relation.ispartofOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanceren_US
dc.subjectChemotherapeutic Agentsen_US
dc.subjectHepatotoxicityen_US
dc.titleCancer Chemotherapy and Liveren_US
dc.title.alternativeKanser Kemoterapisi ve Karaciğeren_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu